Why Every Fractional CFO Should Have an R&D Tax Strategy in Their Financial Toolkit

The role of the CFO has changed considerably over the past decade. Whether that's a full-time CFO, a Finance Director, or a Fractional CFO working across several businesses, today's finance leaders are expected to do a lot more than manage budgets and oversee compliance. Cash flow, working capital, investor relationships, funding strategy, shareholder value: all of it now sits within the finance function's remit, often held by one person covering ground that used to be split across a whole team.

R&D Tax Relief is one area that hasn't always kept pace with that shift. It's often still treated as a specialist tax exercise, handled after year-end by whoever prepares the accounts, rather than something that sits inside the broader financial strategy a CFO is already building. That's a gap worth closing, because when it's approached strategically, R&D relief is a genuine source of non-dilutive funding that can strengthen a company's financial position, improve liquidity and support the next phase of investment.

For a Fractional CFO specifically, working across a portfolio of different businesses, knowing how to spot, assess and manage R&D opportunities is becoming a genuinely valuable part of the toolkit, not a niche add-on.

R&D Tax Relief Is No Longer Just About Tax

One of the most common misconceptions about R&D relief is that it belongs entirely to the tax function. In practice, a strong claim starts long before anyone prepares a corporation tax return. It starts with business strategy, in decisions finance leaders are already involved in:

• Product development

• Software investment

• Process improvements

• Manufacturing innovation

• Automation and AI implementation

• Hiring technical teams

• Capital allocation and investment planning

Plenty of these decisions involve genuinely qualifying R&D activity, often without anyone in the room realising it at the time. CFOs who build R&D into wider financial planning, rather than treating it as something to look at retrospectively, tend to see the benefit show up well beyond the claim itself: better forecasting, sharper investment decisions, stronger cash flow, and more confidence in the numbers behind future growth.

The CFO's Perspective Is Different

An accountant, understandably, tends to ask whether a piece of expenditure qualifies. That's the right question for their role. A CFO is usually asking something else entirely:

• How much additional cash could this realistically generate?

• Could this fund the next phase of recruitment?

• Does it reduce how much external investment we need to raise?

• What does it do to EBITDA?

• How will investors read it?

• Does it strengthen the balance sheet?

• Does it extend our cash runway?

That's not a reflection on either role. It's simply a different lens, and it's the lens that turns R&D relief from an isolated tax project into part of the wider financial strategy a CFO is already responsible for.

Non-Dilutive Capital Every CFO Should Consider

Growing businesses are constantly weighing investment against cash preservation, usually choosing between some combination of equity investment, bank lending, asset finance, venture debt, grants and internal reserves. R&D Tax Relief deserves a place in that same conversation.

Unlike equity, it doesn't dilute ownership. Unlike debt, there's nothing to repay. Unlike a funding round, the business keeps complete control over the outcome. For a genuinely innovative company, that combination makes it one of the more attractive funding mechanisms available, and the capital it releases can support recruitment, product development, software work, market expansion, equipment purchases or the next stage of automation. From a CFO's seat, that's flexibility that doesn't come with strings attached.

Better Forecasting Starts Earlier

R&D relief is still, in a lot of businesses, something that gets submitted after year-end without ever being factored into the budgeting process itself. That's a missed opportunity, not because anyone's done anything wrong, but because the relief arrives too late to inform decisions it could genuinely have shaped.

A CFO who builds R&D into forecasting is asking a slightly different set of questions earlier: what qualifying activity is likely this year, what expenditure sits behind it, what relief that could realistically generate, and how that changes the cash forecast or the need for external borrowing. Bringing estimated relief into the financial model, rather than waiting for the accounts to be finalised, means decisions get made with a fuller picture, not a partial one.

Cash Flow Is More Important Than Ever

Higher interest rates, ongoing economic uncertainty, inflationary pressure and longer customer payment cycles are all putting pressure on working capital right now, across almost every sector. Cash flow itself has rarely mattered more.

R&D relief is one of the few levers available that strengthens liquidity without adding debt. For a CFO managing several businesses at once, that kind of resilience is often worth more than an equivalent improvement in headline profitability, simply because it gives every one of those businesses more room to manoeuvre when conditions are tight.

Risk Has Increased. So Has the Need for Specialists.

The UK's R&D landscape has changed considerably, and it's worth being upfront about that. HMRC has introduced more compliance activity, the Additional Information Form, claim notification requirements in some circumstances, closer scrutiny of technical reports, and more detailed cost analysis. Enquiry activity has increased too.

None of that is a reason to be cautious about legitimate claims. It's a reason to be precise about how they're built, and precise about who's helping build them.

Why Specialist Expertise Matters

A genuinely strong claim draws on tax legislation, but also on a real understanding of the science, engineering, manufacturing or software work behind the project, plus the technical documentation and financial analysis needed to support it properly. That's a wide spread of expertise, and it's entirely reasonable that most finance teams, however capable, won't hold all of it in-house, any more than a generalist accountancy practice would.

That's where a specialist R&D partner earns its place: not replacing the finance team or the existing accountant, but working alongside them so a claim is technically robust, properly evidenced, commercially accurate and fully compliant.

The Value of an Independent Technical Review

It's also worth having a genuinely independent technical review before anything is submitted. Some claims end up overclaimed, which raises enquiry risk. Others end up underclaimed, which simply leaves funding unclaimed that the business was entitled to.

Both outcomes are avoidable. An independent review exists to find the correct position rather than the most convenient one, and it protects the business either way, whether that means confirming a claim is right as it stands or flagging where it needs to be adjusted before HMRC ever sees it.

Building R&D Into Your Financial Toolkit

The Fractional CFOs who stand out tend to be the ones solving problems beyond the finance function itself: spotting funding opportunities, improving operational efficiency, reducing risk, supporting innovation, strengthening governance. R&D Tax Relief fits naturally into that broader role.

Knowing when to flag a potential opportunity and when to bring in specialist support lets a CFO add real value here without needing to carry the technical load personally. It becomes one more tool available across every client relationship, not a separate specialism sitting apart from the rest of the role.

How PSS Tax Supports Fractional CFOs

At PSS Tax, we don't replace accountants or finance teams. We work alongside them. Our specialists partner with Fractional CFOs, Finance Directors and boards to identify genuinely qualifying innovation, build robust technical documentation, and manage the process from initial review through to submission and, where it's needed, HMRC enquiry support.

The aim is straightforward: help finance leaders access legitimate funding while keeping technical risk low. As HMRC's expectations keep evolving, having the right specialist alongside you matters more than it used to, not less.

Final Thoughts

Today's CFO is expected to drive growth, protect cash flow and support innovation, often across more than one business at once. R&D Tax Relief speaks directly to all three. Businesses that treat it as a strategic finance tool, rather than a year-end tax exercise, tend to be in a stronger position to invest, grow and stay competitive. For Fractional CFOs advising multiple businesses, knowing when to spot an opportunity and when to bring in the right specialist expertise isn't just good practice. It's a genuine point of difference. R&D Tax Relief was never really just about recovering historic costs. Done properly, it's about funding what comes next.

About PSS Tax

PSS Tax works alongside accountants, finance directors, fractional CFOs and business owners to deliver specialist R&D Tax Relief support, from identifying qualifying innovation to preparing robust technical narratives and supporting HMRC enquiries. Our focus is helping businesses access every legitimate claim while holding to the highest standards of compliance.